Submissions from 2023
Video Needle Control During Laparoscopic Pancreaticojejunosotmy, Domenech Asbun
Radiosurgery: What are the Questions we Should be Asking?, Minesh Mehta
Great Debates: Fractionated vs. Staged SRT for Brain Metastases, Minesh Mehta
Great Debates: Preopertavive vs. Postopertaive SRS for Brain Metastases, Minesh Mehta
Innovative Radiation Techniques, Minesh Mehta
Diploic Bone Channel Drilling Facilitates Dissection of the Midline Dura and Protects the Superior Sagittal Sinus in Hyperostosis Frontalis Interna, Ahmad Ozair and Michael McDermott
Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options, Michael Chuong
Modern Meningioma Methods: Molecular Diagnostics and High Dose Protons, Rupesh Kotecha and Minesh Mehta
Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma, Manmeet Ahluwalia
Pulmonary Open, Robotic and Thoracoscopic Lobectomy (PORTaL) Study: An Analysis of 5,721 Cases, Mark Dylewski
Educational Scoring System in Laparoscopic Cholecystectomy: Is It the Right Time to Standardize?, Horacio Asbun
FAU Institute for Human Health and Disease Intervention, Suresh Rana
Perceptions of PGY-2 Oncology Programs on Financial Toxicity Education and Preparedness, Monica Tadros
Transformations in Pancreatic Cancer Care, Domenech Asbun
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets, Ahmad Ozair, Atulya Khosla, Rupesh Kotecha, Yazmin Odia, Michael McDermott, and Manmeet Ahluwalia
Dosimetric delivery validation of dynamically collimated pencil beam scanning proton therapy, Jen Yu and Alonso Gutierrez
Keynote: Future of Proton Therapy, Minesh Mehta
An Update on NRG Trials of Hippocampal Avoidance, Minesh Mehta
Implementation of superficial radiation therapy (SRT) using SRT-100 Vision™ for non-melanoma skin cancer in a Radiation Oncology clinic, Cecilia Lee, Stephan Davis, William Romaguera, Vibha Chaswal, Ranjini Tolakanahalli, Alonso Gutierrez, and Noah Kalman
Keeping Your Gallbladder Healthy, Domenech Asbun
Depatuxizumab-mafodotin in EGFR-amplified newly diagnosed glioblastoma: a phase III randomized clinical trial, Minesh Mehta